RecruitingNCT07530770

Real-World Effectiveness of Benralizumab in Allergic Bronchopulmonary Aspergillosis

Studying Allergic bronchopulmonary aspergillosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Qianfoshan Hospital
Principal Investigator
Qian Qi
Shandong First Medical University
Intervention
Fasenra(drug)
Enrollment
20 enrolled
Eligibility
18-75 years · All sexes
Timeline
20252026

Study locations (2)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07530770 on ClinicalTrials.gov

Other trials for Allergic bronchopulmonary aspergillosis

Additional recruiting or active studies for the same condition.

See all trials for Allergic bronchopulmonary aspergillosis

← Back to all trials